GlassScriptPhysician profile
Thomas Matthews Hoopes, II
NPI 1851900674
$1,687.30
in general payments reported to CMS, 2019-2025
8 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what 95% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $99.96 · 2023: $318 · 2024: $13.24 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036 · Education: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.30 |
| Education | $325.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,243.50 | 2021-2025 | Invisalign, Invisalign First - Comprehensive, Itero Element 5d Plus |
| 3m Company | $157.58 | 2021-2023 | Clarity Aligners |
| Ormco Corporation | $116.03 | 2022-2023 | Spark |
| Envista Holdings Corporation | $45.34 | 2024-2025 | Spark |
| Ortho Organizers, INC. | $44.84 | 2021 | |
| Gc America INC. | $32.69 | 2021 | |
| American Orthodontics Corporation | $31.25 | 2025 | Empower-Metal, LP and Ifit Tubes, Radiance |
| Nobel Biocare USA | $16.07 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hoopes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.